Related Experiment Video
Updated: Sep 10, 2025
06:23
The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
Published on: October 13, 2016
32.7K
Association Between Serum Methylmalonic Acid and Poor Cognitive Performance
Ziping Wang1, Yan Deng2, Liangkai Chen3
1Department of Nutrition, Hygiene and Toxicology (ZW, BL, TW, SR), Academy of Nutrition and Health, School of Public Health, Medical College, Wuhan University of Science and Technology, Wuhan, China.
Summary
Higher methylmalonic acid (MMA) levels are linked to poorer cognitive function in older adults, particularly affecting language and attention. This finding may offer new insights into preventing age-related cognitive decline.
Area of Science:
- Gerontology
- Neuroscience
- Biochemistry
Background:
- Methylmalonic acid (MMA) accumulation is increasingly recognized for its role in aging and cancer.
- Limited research exists on the association between MMA and age-related cognitive decline in the elderly.
- Understanding this link may inform strategies for preventing cognitive disorders like dementia.
Purpose of the Study:
- To investigate the association between serum methylmalonic acid (MMA) levels and cognitive function in older adults.
- To explore the relationship between MMA and specific cognitive domains, including memory, language, and attention.
- To provide evidence for the potential role of MMA in age-related cognitive decline.
Main Methods:
- Analysis of data from 2,760 older adults from the National Health and Nutrition Examination Survey.
- Measurement of serum MMA concentrations using gas chromatography/mass spectrophotometry.
- Assessment of cognitive function through neuropsychological tests evaluating immediate memory, delayed memory, language, and attention, alongside global cognition and self-reported subjective cognitive decline.
- Application of weighted linear and logistic regression models to determine the association between MMA and cognitive outcomes.
Main Results:
- Higher MMA levels were associated with poorer cognitive function, notably in language and attention domains.
- Logistic regression indicated that individuals with MMA ≥250 nmol/L had increased odds of poor global cognition (OR: 1.53), language function (OR: 1.56), and attention (OR: 1.48) compared to those with MMA <170 nmol/L.
- Multivariable linear regression revealed a significant inverse association between MMA and global cognitive score (β: -1.84) and attention (β: -2.06).
Conclusions:
- Circulating methylmalonic acid (MMA) is inversely associated with global cognition, language function, and attention in the elderly population.
- Further research is warranted to elucidate the causal relationships and underlying biological mechanisms connecting MMA and cognitive function.
- These findings highlight MMA as a potential biomarker for age-related cognitive decline.
More Related Videos
Related Concept Videos
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
206
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
206
01:26Alzheimer's Disease: Overview
666
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
666
01:30Negative and Cognitive Symptoms of Schizophrenia
123
Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
123